Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/6691936.

Title:
Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors | British Journal of Cancer
Description:
Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. Β© 2001 Cancer Research Campaign http://www.bjcancer.com
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

πŸš€πŸŒ  Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 17,414,592 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$219,500 per month
Our estimates place Nature.com's monthly online earnings from display ads at $146,325 to $402,393.

Keywords {πŸ”}

cancer, growth, article, pubmed, google, scholar, factor, cas, colon, endothelial, nature, receptor, vascular, res, human, content, carcinomatosis, liu, hicklin, ellis, apoptosis, cells, antibody, cookies, antibodies, epidermal, shaheen, bucana, vegf, metastasis, therapy, cell, angiogenesis, research, colorectal, privacy, open, tumour, model, peritoneal, mice, survival, monoclonal, carcinoma, clin, data, journal, access, egf, vivo,

Topics {βœ’οΈ}

nature portfolio privacy policy nature advertising cancer research social media research 0/ reprints antiangiogenic therapy targeting anti-vegf antibody bevacizumab epidermal growth factor endothelial cell apoptosis org/statistics/cff2000/selectedcancers personal data anti-angiogenic therapeutic strategy combination anti-vegf endothelial cell survival tyrosine kinase receptor data protection dc101 inhibits angiogenesis permissions anti-vegfr2 antibody vegf-mediated ascites formation anti-egfr therapy colon peritoneal carcinomatosis human colon cancer human pancreatic carcinoma egf receptor highly metastatic cells hyperthermic intraperitoneal chemotherapy vivo survival factor colon cancer carcinomatosis privacy monoclonal antibodies targeting anti-egfr attenuates explore content similar content surgical oncology inhibit tumour growth generate peritoneal metastases journals search log c225 therapy european economic area beth israel hospital rodriguez-bigas ma zebrowski bk experimental neoplasia putnam jb jr malignant pleural effusions vascular endothelial

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
         description:Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. © 2001 Cancer Research Campaign http://www.bjcancer.com
         datePublished:2001-08-14T00:00:00Z
         dateModified:2011-11-16T00:00:00Z
         pageStart:584
         pageEnd:589
         sameAs:https://doi.org/10.1054/bjoc.2001.1936
         keywords:
            antiangiogenic therapy
            VEGF
            EGF
            receptor
            apoptosis
            endothelial cell
            DC101
            C225
            Biomedicine
            general
            Cancer Research
            Epidemiology
            Molecular Medicine
            Oncology
            Drug Resistance
         image:
         isPartOf:
            name:British Journal of Cancer
            issn:
               1532-1827
               0007-0920
            volumeNumber:85
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:R M Shaheen
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S A Ahmad
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:W Liu
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:N Reinmuth
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Y D Jung
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:W W Tseng
               affiliation:
                     name:Stanford University
                     address:
                        name:Department of Surgery, Stanford University, Palo Alto, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K E Drazan
               affiliation:
                     name:Stanford University
                     address:
                        name:Department of Surgery, Stanford University, Palo Alto, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:C D Bucana
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D J Hicklin
               affiliation:
                     name:ImClone Systems Inc.
                     address:
                        name:ImClone Systems Inc., New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:L M Ellis
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
      description:Vascular endothelial growth factor (VEGF) and epidermal growth factor (EGF) regulate colon cancer growth and metastasis. Previous studies utilizing antibodies against the VEGF receptor (DC101) or EGF receptor (C225) have demonstrated independently that these agents can inhibit tumour growth and induce apoptosis in colon cancer in in vivo and in vitro systems. We hypothesized that simultaneous blockade of the VEGF and EGF receptors would enhance the therapy of colon cancer in a mouse model of peritoneal carcinomatosis. Nude mice were given intraperitoneal injection of KM12L4 human colon cancer cells to generate peritoneal metastases. Mice were then randomized into one of four treatment groups: control, anti-VEGFR (DC101), anti-EGFR (C225), or DC101 and C225. Relative to the control group, treatment with DC101 or with DC101+C225 decreased tumour vascularity, growth, proliferation, formation of ascites and increased apoptosis of both tumour cells and endothelial cells. Although C225 therapy did not change any of the above parameters, C225 combined with DC101 led to a significant decrease in tumour vascularity and increases in tumour cell and endothelial cell apoptosis (vs the DC101 group). These findings suggest that DC101 inhibits angiogenesis, endothelial cell survival, and VEGF-mediated ascites formation in a murine model of colon cancer carcinomatosis. The addition of C225 to DC101 appears to lead to a further decrease in angiogenesis and ascites formation. Combination anti-VEGF and anti-EGFR therapy may represent a novel therapeutic strategy for the management of colon peritoneal carcinomatosis. © 2001 Cancer Research Campaign http://www.bjcancer.com
      datePublished:2001-08-14T00:00:00Z
      dateModified:2011-11-16T00:00:00Z
      pageStart:584
      pageEnd:589
      sameAs:https://doi.org/10.1054/bjoc.2001.1936
      keywords:
         antiangiogenic therapy
         VEGF
         EGF
         receptor
         apoptosis
         endothelial cell
         DC101
         C225
         Biomedicine
         general
         Cancer Research
         Epidemiology
         Molecular Medicine
         Oncology
         Drug Resistance
      image:
      isPartOf:
         name:British Journal of Cancer
         issn:
            1532-1827
            0007-0920
         volumeNumber:85
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:R M Shaheen
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S A Ahmad
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:W Liu
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:N Reinmuth
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Y D Jung
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:W W Tseng
            affiliation:
                  name:Stanford University
                  address:
                     name:Department of Surgery, Stanford University, Palo Alto, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K E Drazan
            affiliation:
                  name:Stanford University
                  address:
                     name:Department of Surgery, Stanford University, Palo Alto, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:C D Bucana
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D J Hicklin
            affiliation:
                  name:ImClone Systems Inc.
                  address:
                     name:ImClone Systems Inc., New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:L M Ellis
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:British Journal of Cancer
      issn:
         1532-1827
         0007-0920
      volumeNumber:85
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Stanford University
      address:
         name:Department of Surgery, Stanford University, Palo Alto, USA
         type:PostalAddress
      name:Stanford University
      address:
         name:Department of Surgery, Stanford University, Palo Alto, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:ImClone Systems Inc.
      address:
         name:ImClone Systems Inc., New York, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:R M Shaheen
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:S A Ahmad
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:W Liu
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:N Reinmuth
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Y D Jung
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:W W Tseng
      affiliation:
            name:Stanford University
            address:
               name:Department of Surgery, Stanford University, Palo Alto, USA
               type:PostalAddress
            type:Organization
      name:K E Drazan
      affiliation:
            name:Stanford University
            address:
               name:Department of Surgery, Stanford University, Palo Alto, USA
               type:PostalAddress
            type:Organization
      name:C D Bucana
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:D J Hicklin
      affiliation:
            name:ImClone Systems Inc.
            address:
               name:ImClone Systems Inc., New York, USA
               type:PostalAddress
            type:Organization
      name:L M Ellis
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Surgery, Stanford University, Palo Alto, USA
      name:Department of Surgery, Stanford University, Palo Alto, USA
      name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:ImClone Systems Inc., New York, USA
      name:Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, USA

Social Networks {πŸ‘}(1)

External Links {πŸ”—}(79)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.51s.